Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   

The Angels Initiative

Stroke prevention

  Liver Diseases

  Free Subscription

Articles published in Am J Gastroenterol

Retrieve available abstracts of 142 articles:
HTML format

Single Articles

    November 2022
  1. MATCHETT CL, Rattan P, McConnell JP, Donato LJ, et al
    Chylous Ascites: Reassessment of Diagnostic Criteria in Patients With Portal Hypertension.
    Am J Gastroenterol. 2022 Nov 16. pii: 00000434-990000000-00561.
    PubMed     Abstract available

  2. KRAMER JR, Cao Y, Li L, Smith D, et al
    Longitudinal Associations of Risk Factors and Hepatocellular Carcinoma in Patients With Cured Hepatitis C Virus Infection.
    Am J Gastroenterol. 2022;117:1834-1844.
    PubMed     Abstract available

    October 2022
  3. CARUSO S, Miraglia R, Alonzo L, Farinella M, et al
    A Rare Portopulmonary Arteriovenous Fistula in a Cirrhotic Patient with Portal Hypertension and Inversion of Blood Flow after Liver Transplantation.
    Am J Gastroenterol. 2022 Oct 6. pii: 00000434-990000000-00541.

  4. REAU N, Munoz SJ, Schiano T
    Liver Disease During Pregnancy.
    Am J Gastroenterol. 2022;117.

  5. HE K, Guo LL, Tang H, Peng X, et al
    A Freshwater Fish-Based Diet Alleviates Liver Steatosis by Modulating Gut Microbiota and Metabolites: A Clinical Randomized Controlled Trial in Chinese Participants With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:1621-1631.
    PubMed     Abstract available

  6. JAMALI T, Raasikh T, Bustamante G, Sisson A, et al
    Outcomes of Exercise Interventions in Patients With Advanced Liver Disease: A Systematic Review of Randomized Clinical Trials.
    Am J Gastroenterol. 2022;117:1614-1620.
    PubMed     Abstract available

  7. LIU C, Cao Z, Yan H, Wong YJ, et al
    A Novel SAVE Score to Stratify Decompensation Risk in Compensated Advanced Chronic Liver Disease (CHESS2102): An International Multicenter Cohort Study.
    Am J Gastroenterol. 2022;117:1605-1613.
    PubMed     Abstract available

  8. LIAO KF, Hwang BF, Liu CS, Lai SW, et al
    Aspirin Use and the Risk of Liver Cancer.
    Am J Gastroenterol. 2022;117:1718.

  9. DEVARBHAVI H, Kurien SS, Raj S, Patil M, et al
    Idiosyncratic Drug-Induced Liver Injury Associated With and Without Drug Reaction With Eosinophilia and Systemic Symptoms.
    Am J Gastroenterol. 2022;117:1709-1713.
    PubMed     Abstract available

    September 2022
  10. CAILES DB, Farouque AO, Majumdar AA, Koshy DAN, et al
    Title: Cardiac Dysfunction in the Pathogenesis of Hepatorenal Syndrome.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00535.

  11. LIN TAY PW, Ng CH, Lin SY, Chin YH, et al
    Placebo Adverse Events in Non-Alcoholic Steatohepatitis Clinical Trials. A Pooled Analysis of 2,944 Participants.
    Am J Gastroenterol. 2022 Sep 30. pii: 00000434-990000000-00528.
    PubMed     Abstract available

  12. SERPER M, Tapper EB, Kaplan DE, Taddei TH, et al
    Patterns of Care Utilization and Hepatocellular Carcinoma Surveillance: Tracking Care Across the Pandemic.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00513.
    PubMed     Abstract available

  13. GUPTA A, Rana R, Agarwal S, Sharma S, et al
    Assessing the risk of further decompensation and survival in patients with cirrhosis with variceal bleeding as their first decompensation event.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00510.
    PubMed     Abstract available

  14. SINGAL AG, Reig M, Villanueva A
    Emerging Tools for Hepatocellular Carcinoma Surveillance.
    Am J Gastroenterol. 2022 Sep 16. pii: 00000434-990000000-00505.

  15. ZACCHERINI G, Baldassarre M, Tufoni M, Nardelli S, et al
    Correction and prevention of hyponatremia in patients with cirrhosis and ascites - Post hoc analysis of the ANSWER study database.
    Am J Gastroenterol. 2022 Sep 6. pii: 00000434-990000000-00502.
    PubMed     Abstract available

  16. HAYASHI PH, Lucena MI, Fontana RJ
    RECAM: A New and Improved, Computerized Causality Assessment Tool for DILI Diagnosis.
    Am J Gastroenterol. 2022;117:1387-1389.

  17. TAO Z, Wang H, Du Z, Zhang Y, et al
    Anorectal Variceal Bleeding Treated by Sclerotherapy.
    Am J Gastroenterol. 2022;117:1403.

  18. FAN L, Zhu X, Shingina A, Kabagambe EK, et al
    Racial Disparities in Associations of Alcohol Consumption With Liver Disease Mortality in a Predominantly Low-Income Population: A Report From the Southern Community Cohort Study.
    Am J Gastroenterol. 2022;117:1523-1529.
    PubMed     Abstract available

    August 2022
  19. RAHAL HK, Tabibian JH, Issaka RB, Quezada S, et al
    Diversity, Equity, and Inclusion in Gastroenterology and Hepatology: A Survey of Where We Stand.
    Am J Gastroenterol. 2022 Aug 25. pii: 00000434-990000000-00492.
    PubMed     Abstract available

    The Ongoing Debate of Serum Ammonia Levels in Cirrhosis: The Good, The Bad, and The Ugly.
    Am J Gastroenterol. 2022 Aug 23. pii: 00000434-990000000-00488.
    PubMed     Abstract available

  21. WENTWORTH BJ, Henry ZH, Siragy HM
    How I Approach It: Adrenal Insufficiency in Cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00445.

  22. BHAVSAR-BURKE I, Guardiola JJ, Hamade N, Gerke S, et al
    Use of a cirrhosis admission order set improves adherence to quality metrics and may decrease hospital length of stay.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00463.
    PubMed     Abstract available

  23. KUTMUTIA R, Tittanegro T, China L, Forrest E, et al
    Evaluating the role of antibiotics in patients admitted to hospital with decompensated cirrhosis: lessons from the ATTIRE trial.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00458.
    PubMed     Abstract available

  24. TANDON P, Pidborochynski T, Abraldes JG, Carbonneau M, et al
    The assessment of driving fitness using an on-road driving evaluation in patients with cirrhosis.
    Am J Gastroenterol. 2022 Aug 12. pii: 00000434-990000000-00462.
    PubMed     Abstract available

  25. WONG F
    The Cardiorenal Connection: Is Cardiac Output the Sole Determinant of Renal Dysfunction in Cirrhosis?
    Am J Gastroenterol. 2022;117:1242-1243.
    PubMed     Abstract available

  26. DANIELSEN KV, Wiese S, Busk T, Nabilou P, et al
    Cardiovascular Mapping in Cirrhosis From the Compensated Stage to Hepatorenal Syndrome: A Magnetic Resonance Study.
    Am J Gastroenterol. 2022;117:1269-1278.
    PubMed     Abstract available

  27. LONG A, Magrath M, Mihalopoulos M, Rule JA, et al
    Changes in Epidemiology of Acetaminophen Overdoses in an Urban County Hospital After 20 Years.
    Am J Gastroenterol. 2022;117:1324-1328.
    PubMed     Abstract available

    July 2022
  28. PARK D, Houston K, Duong NK, Dharia N, et al
    Am J Gastroenterol. 2022 Jul 21. pii: 00000434-990000000-00442.
    PubMed     Abstract available

  29. VUTIEN P, Berry K, Feng Z, VoPham T, et al
    Combining FIB-4 and liver stiffness into the FIB-5, a single model that accurately predicts complications of portal hypertension.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00435.
    PubMed     Abstract available

  30. ASRANI SK, Hall L, Reddy V, Ogola G, et al
    Comorbid chronic diseases and survival in compensated and decompensated cirrhosis: a population-based study.
    Am J Gastroenterol. 2022 Jul 15. pii: 00000434-990000000-00436.
    PubMed     Abstract available

    June 2022
  31. MOON AM, Ioannou GN
    Moving Away from a One-Size-Fits-All Approach to Hepatocellular Carcinoma Surveillance.
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00430.

  32. INNES H, Hamill V, McDonald SA, Hayes PC, et al
    Comparing predicted probability of hepatocellular carcinoma in cirrhosis patients to the general population: an opportunity to improve risk communication?
    Am J Gastroenterol. 2022 Jun 24. pii: 00000434-990000000-00428.
    PubMed     Abstract available

  33. CALVARUSO V, Celsam C, D'Ambrosio R, Simone F, et al
    RESIST-HCV criteria to monitor progression of low-risk esophageal varices in patients with compensated cirrhosis after HCV eradication. The SIMPLE study: SIMPLE: Scoring Index to Monitor Progression of Low-risk Esophageal varices.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00413.
    PubMed     Abstract available

  34. DAJTI E, Ravaioli F, Marasco G, Alemanni LV, et al
    A combined Baveno VII and spleen stiffness algorithm to improve the non-invasive diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease.
    Am J Gastroenterol. 2022 Jun 17. pii: 00000434-990000000-00415.
    PubMed     Abstract available

  35. BAJAJ JS, Wong F, Kamath PS, Lai JC, et al
    Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:831-834.

  36. SCORLETTI E, Creasy KT, Vujkovic M, Vell M, et al
    Dietary Vitamin E Intake Is Associated With a Reduced Risk of Developing Digestive Diseases and Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:927-930.
    PubMed     Abstract available

  37. KANN AE, Jepsen P, Madsen LG, Crooks C, et al
    Motivation to Reduce Drinking and Engagement in Alcohol Misuse Treatment in Alcohol-Related Liver Disease: A National Health Survey.
    Am J Gastroenterol. 2022;117:918-922.
    PubMed     Abstract available

    May 2022
  38. ACHANTA CR, Kinhal SV, Imandi V, Singh A, et al
    Motorized Spiral Enteroscope Guided Biliary Intervention for Treatment of Biliary Obstruction in Patient with HepaticoJejunostomy.
    Am J Gastroenterol. 2022 May 9. pii: 00000434-990000000-00372.

  39. CROCOMBE D, Freemantle N, O'Brien A
    Additional Analyses for the Published Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:814-815.

  40. MIR BA, Majeed T, Chauhan A
    A New Window to Favorable Outcome in Acute-on-Chronic Liver Failure.
    Am J Gastroenterol. 2022;117:815.

    April 2022
  41. RASHMI KG, Sahoo J
    Correspondence from Rashmi et al " Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial ".
    Am J Gastroenterol. 2022 Apr 15. pii: 00000434-990000000-00344.

  42. TAPPER EB, Salim N, Baki J, Zhao Z, et al
    Pickle Juice Intervention for Cirrhotic Cramps Reduction: The PICCLES Randomized Controlled Trial.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00331.
    PubMed     Abstract available

  43. YAMASHITA M, Kugiyama T, Takei D, Hara Y, et al
    An Unexpected Case of Fishbone-Induced Liver Abscess Through the Gallbladder.
    Am J Gastroenterol. 2022 Apr 13. pii: 00000434-990000000-00328.

  44. RAO A, Rule JA, Hameed B, Ganger D, et al
    Secular Trends in Severe Idiosyncratic Drug-Induced Liver Injury in North America: An Update From the Acute Liver Failure Study Group Registry.
    Am J Gastroenterol. 2022;117:617-626.
    PubMed     Abstract available

  45. KULKARNI AV, Tirumalle S, Premkumar M, Kumar K, et al
    Primary Norfloxacin Prophylaxis for APASL-Defined Acute-on-Chronic Liver Failure: A Placebo-Controlled Double-Blind Randomized Trial.
    Am J Gastroenterol. 2022;117:607-616.
    PubMed     Abstract available

    March 2022
  46. SHAHA S, Gao Y, Huang J, Imbertson E, et al
    Successful Treatment of Superior Mesenteric Artery Syndrome with Percutaneous Endoscopic Gastrojejunostomy in a Sarcopenic Patient with Cirrhosis.
    Am J Gastroenterol. 2022 Mar 28. pii: 00000434-990000000-00308.

  47. LAMMERT C, Toal E, Mathur K, Khungar V, et al
    Large Hepatic Adenomas and Hepatic Adenomatosis: A multicenter study of risk factors, interventions, and complications.
    Am J Gastroenterol. 2022 Mar 23. pii: 00000434-990000000-00302.
    PubMed     Abstract available

  48. COSTA MS, Agostinho C, Figueiredo P
    Abdominal Wall Invasion of Hepatocellular Carcinoma.
    Am J Gastroenterol. 2022 Mar 16. pii: 00000434-990000000-00288.

  49. VIEIRA BARBOSA J, Milligan S, Frick A, Broestl J, et al
    Fibrosis-4 Index Can Independently Predict Major Adverse Cardiovascular Events in Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2022;117:453-461.
    PubMed     Abstract available

  50. DUARTE-ROJO A, Sejdic E
    Artificial Intelligence and the Risk for Intuition Decline in Clinical Medicine.
    Am J Gastroenterol. 2022;117:401-402.
    PubMed     Abstract available

  51. LEE HL, Lin MC, Yeh FC, Tsai MK, et al
    Klebsiella pneumoniae Invasive Syndrome With Ventriculitis.
    Am J Gastroenterol. 2022;117:372.

    February 2022
  52. UFERE NN, Patzer RE, Kavalieratos D, Louissaint J, et al
    Rural-Urban Disparities in Mortality from Cirrhosis in the United States from 1999 to 2019.
    Am J Gastroenterol. 2022 Feb 25. pii: 00000434-990000000-00270.

  53. LEVY MJ, Bendel EC, Bjarnason H, Reisenauer CJ, et al
    Endoscopic Ultrasound Guided Dual Ultrasound Hepatic Cyst Aspiration and Sclerotherapy to Ameliorate Portal Hypertension.
    Am J Gastroenterol. 2022 Feb 17. pii: 00000434-990000000-00261.

  54. LEONTIADIS GI, Longstreth GF
    Evolutionary medicine perspectives: H. pylori, lactose intolerance, and three hypotheses for functional and inflammatory gastrointestinal and hepatobiliary disorders.
    Am J Gastroenterol. 2022 Feb 15. pii: 00000434-990000000-00250.
    PubMed     Abstract available

  55. ZHAO Y, Li X, Yang S, Tao Y, et al
    Small-Diameter Drug-Eluting Beads-Based Transarterial Chemoemboli-zation (DEB-TACE) for Treating Patients With Esophageal Cancer With Acute Bleeding.
    Am J Gastroenterol. 2022 Feb 8. pii: 00000434-990000000-00244.

  56. PENG T, Lu H, Deng L, Li Q, et al
    Diffuse intrahepatic bile duct hamartomas.
    Am J Gastroenterol. 2022 Feb 3. pii: 00000434-990000000-00241.

  57. BAJAJ JS, O'Leary JG, Lai JC, Wong F, et al
    Acute-on-Chronic Liver Failure Clinical Guidelines.
    Am J Gastroenterol. 2022;117:225-252.
    PubMed     Abstract available

  58. VAN KLEEF LA, Hofman A, Voortman T, de Knegt RJ, et al
    Objectively Measured Physical Activity Is Inversely Associated With Nonalcoholic Fatty Liver Disease: The Rotterdam Study.
    Am J Gastroenterol. 2022;117:311-318.
    PubMed     Abstract available

  59. YU S, Pan L, Ma J, Cao H, et al
    The Underlying Cause of Esophageal Variceal Bleeding: Hereditary Thrombophilia.
    Am J Gastroenterol. 2022;117:217.

    January 2022
  60. YUAN L, Hanlon CL, Terrault N, Alqahtani S, et al
    Portrait of Regional Trends in Liver Transplantation for Nonalcoholic Steatohepatitis in the United States.
    Am J Gastroenterol. 2022 Jan 27. pii: 00000434-990000000-00229.
    PubMed     Abstract available

  61. LOUISSAINT J, Grzyb K, Bashaw L, Mohammad RA, et al
    An Electronic Decision Support Intervention Reduces Readmissions for Patients With Cirrhosis.
    Am J Gastroenterol. 2022 Jan 12. pii: 00000434-990000000-00194.
    PubMed     Abstract available

  62. GONZALEZ SA, Velez JCQ
    Board Review Vignette: Lessons Learned in the Management of Hepatorenal Syndrome Type 1 with Terlipressin.
    Am J Gastroenterol. 2022 Jan 5. pii: 00000434-990000000-00198.

    December 2021
  63. AHN JC, Attia ZI, Rattan P, Mullan AF, et al
    Development of the AI-Cirrhosis-ECG (ACE) Score: An electrocardiogram-based deep learning model in cirrhosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00204.
    PubMed     Abstract available

  64. KIM NJ, Rozenberg-Ben-Dror K, Jacob DA, Berry K, et al
    The COVID-19 pandemic highlights opportunities to improve hepatocellular carcinoma screening and diagnosis in a national health system: COVID-19 and HCC screening and diagnosis.
    Am J Gastroenterol. 2021 Dec 29. pii: 00000434-990000000-00201.
    PubMed     Abstract available

  65. HUANG AC, Grab J, Flemming JA, Dodge JL, et al
    Pregnancies With Cirrhosis Are Rising and Associated With Adverse Maternal and Perinatal Outcomes.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00172.
    PubMed     Abstract available

  66. VAN DE BRUAENE C, Houthoofd B, De Coninck S
    A Hepatic Change of Mind.
    Am J Gastroenterol. 2021 Dec 20. pii: 00000434-990000000-00169.

  67. CACOUB P, Asselah T
    Hepatitis B Virus Infection and Extra-Hepatic Manifestations: A Systemic Disease.
    Am J Gastroenterol. 2021 Dec 16. pii: 00000434-990000000-00166.
    PubMed     Abstract available

  68. LV Y, Bai W, Li K, Wang Z, et al
    Correction to: Anticoagulation and Transjugular Intrahepatic Portosystemic Shunt for the Management of Portal Vein Thrombosis in Cirrhosis: A Prospective Observational Study.
    Am J Gastroenterol. 2021 Dec 9. pii: 00000434-990000000-00159.

  69. LIZAOLA-MAYO BC, Mathur AK, Borad MJ, Jadlowiec CC, et al
    Immunotherapy as a Downstaging Tool for Liver Transplantation in Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:2478-2480.

  70. HARRISON SA, Baum SJ, Gunn NT, Younes ZH, et al
    Safety, Tolerability, and Biologic Activity of AXA1125 and AXA1957 in Subjects With Nonalcoholic Fatty Liver Disease.
    Am J Gastroenterol. 2021;116:2399-2409.
    PubMed     Abstract available

  71. BERK C, Ammar T, Lee BT
    Acute Liver Failure due to Manufactured Alkaline Water: A Case Series of "Real Water"-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:2476-2477.

  72. MEDAS R, Garrido I, Coelho R, Macedo G, et al
    Extensive Abdominal Wall Hematoma After Paracentesis.
    Am J Gastroenterol. 2021;116:2325.

    November 2021
  73. KEHAR M, Griffiths R, Flemming JA
    Increasing Incidence of Cirrhosis Over the Past 2 Decades Among Children in Ontario, Canada.
    Am J Gastroenterol. 2021 Nov 18. pii: 00000434-990000000-00150.
    PubMed     Abstract available

  74. DAWOD E, Nieto J, Saab S
    Endoscopic Ultrasound-Guided Liver Biopsy: Where Do We Stand?
    Am J Gastroenterol. 2021 Nov 17. pii: 00000434-990000000-00146.

  75. DUONG NK, Shrestha S, Park D, Shahab O, et al
    Bristol Stool Scale as a Determinant of Hepatic Encephalopathy Management in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Nov 5. pii: 00000434-990000000-00135.
    PubMed     Abstract available

  76. YANG D, Zhuang B, Xie X
    Hepatic Angiofibroma of Soft tissue: A Case Report.
    Am J Gastroenterol. 2021 Nov 4. pii: 00000434-990000000-00140.

  77. KIM Y, Chang Y, Kwon MJ, Hong YS, et al
    Fasting Ketonuria and the Risk of Incident Nonalcoholic Fatty Liver Disease With and Without Liver Fibrosis in Nondiabetic Adults.
    Am J Gastroenterol. 2021;116:2270-2278.
    PubMed     Abstract available

    October 2021
  78. WEBER S, Gerbes AL
    Ashwagandha-Induced Liver Injury: Self-Reports on Commercial Websites as Useful Adjunct Tools for Causality Assessment.
    Am J Gastroenterol. 2021;116:2151-2152.

  79. GAO X, Gao Y, Ye X, Kang W, et al
    Rare Multiple Liver Lesions With Concentric Circle Pattern.
    Am J Gastroenterol. 2021;116:1979.

  80. LIN FP, Visina JM, Bloomer PM, Dunn MA, et al
    Prehabilitation-Driven Changes in Frailty Metrics Predict Mortality in Patients With Advanced Liver Disease.
    Am J Gastroenterol. 2021;116:2105-2117.
    PubMed     Abstract available

  81. BOIKE JR, Mazumder NR, Kolli KP, Ge J, et al
    Outcomes After TIPS for Ascites and Variceal Bleeding in a Contemporary Era-An ALTA Group Study.
    Am J Gastroenterol. 2021;116:2079-2088.
    PubMed     Abstract available

    "Sickeningly Sweet".... High-Fructose Corn Syrup-Caveat Emptor!
    Am J Gastroenterol. 2021;116:1970-1971.

    September 2021
  83. TRIPATHI PR, Sen Sarma M, Yachha SK, Aggarwal A, et al
    Relative Adrenal Insufficiency in Decompensated Cirrhotic Children: Does It Affect Outcome?
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00094.
    PubMed     Abstract available

  84. LEE HW, Park SY, Lee YR, Lee H, et al
    Episodic Detectable Viremia Does Not Affect Prognosis in Untreated Compensated Cirrhosis With Serum Hepatitis B Virus DNA <2,000 IU/mL.
    Am J Gastroenterol. 2021 Sep 10. pii: 00000434-990000000-00096.
    PubMed     Abstract available

  85. CHINA L, Freemantle N, Forrest E, Kallis Y, et al
    Targeted Albumin Therapy Does Not Improve Short-Term Outcome in Hyponatremic Patients Hospitalized With Complications of Cirrhosis: Data From the ATTIRE Trial.
    Am J Gastroenterol. 2021 Sep 9. pii: 00000434-990000000-00104.
    PubMed     Abstract available

  86. SHAH BJ, Onken JE, Edgar L, Jou JH, et al
    Development of gastroenterology and transplant hepatology milestones 2.0: a guide for programs, faculty, and fellows.
    Am J Gastroenterol. 2021 Sep 7. pii: 00000434-990000000-00088.

  87. BLOOM PP, Robin J, Xu M, Arvind A, et al
    Hepatic Encephalopathy is Associated With Slow Speech on Objective Assessment.
    Am J Gastroenterol. 2021;116:1950-1953.
    PubMed     Abstract available

  88. CASTELLANA M, Donghia R, Guerra V, Procino F, et al
    Fibrosis-4 Index vs Nonalcoholic Fatty Liver Disease Fibrosis Score in Identifying Advanced Fibrosis in Subjects With Nonalcoholic Fatty Liver Disease: A Meta-Analysis.
    Am J Gastroenterol. 2021;116:1833-1841.
    PubMed     Abstract available

  89. THULUVATH PJ, Alukal JJ, Zhang T
    A Scoring Model to Predict In-Hospital Mortality in Patients With Budd-Chiari Syndrome.
    Am J Gastroenterol. 2021;116:1905-1912.
    PubMed     Abstract available

    August 2021
  90. SACK JS, Liu AF, Gray M, Roat J, et al
    Association of Terry Nails With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 27. pii: 00000434-990000000-00085.
    PubMed     Abstract available

  91. FU XL, Chen HL
    COVID-19 Vaccine for Chronic Gastroenterology and Hepatology Patients: A Need for Better Evidence.
    Am J Gastroenterol. 2021 Aug 17. pii: 00000434-990000000-00073.

  92. RODRIGUEZ M, Gonzalez-Dieguez ML, Varela M, Cadahia V, et al
    Impact of Alcohol Abstinence on the Risk of Hepatocellular Carcinoma in Patients With Alcohol-Related Liver Cirrhosis.
    Am J Gastroenterol. 2021 Aug 16. pii: 00000434-990000000-00111.
    PubMed     Abstract available

  93. SCHNEIDER CV, Fromme M, Schneider KM, Bruns T, et al
    Mortality in Patients With Genetic and Environmental Risk of Liver Disease.
    Am J Gastroenterol. 2021;116:1741-1745.
    PubMed     Abstract available

  94. TAGUCHI YV, Snyder DL, Shah JB, Dickson RC, et al
    Deglutition Syncope After Variceal Band Ligation.
    Am J Gastroenterol. 2021;116:1763.

  95. HASHEMIAN M, Merat S, Poustchi H, Jafari E, et al
    Red Meat Consumption and Risk of Nonalcoholic Fatty Liver Disease in a Population With Low Meat Consumption: The Golestan Cohort Study.
    Am J Gastroenterol. 2021;116:1667-1675.
    PubMed     Abstract available

    July 2021
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    PubMed     Abstract available

  97. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.

  98. USHIDA K, Shimizu M, Yamamoto Y, Momosaki R, et al
    Strategies to Improve Exercise Adherence in Patients With Cirrhosis.
    Am J Gastroenterol. 2021 Jul 13. pii: 00000434-990000000-00043.

  99. PINYOPORNPANISH K, Al-Yaman W, Butler RS, Carey W, et al
    Chemopreventive Effect of Statin on Hepatocellular Carcinoma in Patients With Nonalcoholic Steatohepatitis Cirrhosis.
    Am J Gastroenterol. 2021 Jul 2. pii: 00000434-990000000-00036.
    PubMed     Abstract available

  100. MATTOS AZ, Leao GS, Bombassaro IZ, Chiesa T, et al
    Definitions for Acute-on-Chronic Liver Failure: In Dubio Pro Reo.
    Am J Gastroenterol. 2021;116:1550.

  101. VAN J, Aloman C, Reau N
    Potential Bias and Misconceptions in Liver Transplantation for Alcohol- and Obesity-Related Liver Disease.
    Am J Gastroenterol. 2021 Jul 1. pii: 00000434-990000000-00032.
    PubMed     Abstract available

    June 2021
  102. JINDAL A, Mukund A
    Management of Portal Vein Thrombosis in Cirrhosis-Need a Closer Look!
    Am J Gastroenterol. 2021 Jun 30. pii: 00000434-990000000-00025.

  103. ZHAI LL, Tang ZG
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: Several Confounding Factors.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00016.

  104. REIG A, Alvarez-Navascues C, Vergara M, Gomez-Dominguez E, et al
    Obeticholic Acid and Fibrates in Primary Biliary Cholangitis: Comparative Effects in a Multicentric Observational Study.
    Am J Gastroenterol. 2021 Jun 23. pii: 00000434-990000000-00017.
    PubMed     Abstract available

  105. ACHARYA C, Nadhem O, Shaw J, Hassouneh R, et al
    Liver-Unrelated Comorbid Conditions Do Not Affect Cognitive Performance or Hepatic Encephalopathy Progression in Cirrhosis.
    Am J Gastroenterol. 2021 Jun 18. pii: 00000434-990000000-00012.
    PubMed     Abstract available

  106. LOUISSAINT J, May FP, Williams S, Tapper EB, et al
    Effective Mentorship as a Means to Recruit, Retain, and Promote Underrepresented Minorities in Academic Gastroenterology and Hepatology.
    Am J Gastroenterol. 2021;116:1110-1113.

  107. CRAVEN LJ, Parvathy SN, Burton JP, Silverman MS, et al
    Response to Ianiro et al.
    Am J Gastroenterol. 2021;116:1361-1362.

  108. IANIRO G, Porcari S, Gasbarrini A, Cammarota G, et al
    Quantity of Donor Stool for Fecal Microbiota Transplantation: The More, the Better?
    Am J Gastroenterol. 2021;116:1360-1361.

  109. BENMASSAOUD A, Tsochatzis E
    Response to Debnath and Rathi.
    Am J Gastroenterol. 2021;116:1358-1359.

  110. DEBNATH P, Rathi P
    Sarcopenia and TIPS: How Best to Measure Muscle Mass.
    Am J Gastroenterol. 2021;116:1358.

  111. WU F, Pahkala K, Juonala M, Jaakkola J, et al
    Childhood and Adulthood Passive Smoking and Nonalcoholic Fatty Liver in Midlife: A 31-year Cohort Study.
    Am J Gastroenterol. 2021;116:1256-1263.
    PubMed     Abstract available

    May 2021
  112. HERNANDEZ-CONDE M, Llop E, Gomez-Pimpollo L, Fernandez Carrillo C, et al
    Adding Branched-Chain Amino Acids to an Enhanced Standard-of-Care Treatment Improves Muscle Mass of Cirrhotic Patients With Sarcopenia: A Placebo-Controlled Trial.
    Am J Gastroenterol. 2021 May 26. pii: 00000434-900000000-98756.
    PubMed     Abstract available

  113. FARUQUI S, Okoli FC, Olsen SK, Feldman DM, et al
    Cholangiopathy After Severe COVID-19: Clinical Features and Prognostic Implications.
    Am J Gastroenterol. 2021 May 17. pii: 00000434-900000000-98779.
    PubMed     Abstract available

  114. JOHN BV, Khakoo NS, Schwartz KB, Aitchenson G, et al
    Ursodeoxycholic Acid Response Is Associated With Reduced Mortality in Primary Biliary Cholangitis With Compensated Cirrhosis.
    Am J Gastroenterol. 2021 May 13. pii: 00000434-900000000-98782.
    PubMed     Abstract available

  115. GOET JC, Murillo Perez CF, Harms MH, Floreani A, et al
    A Comparison of Prognostic Scores (Mayo, UK-PBC, and GLOBE) in Primary Biliary Cholangitis.
    Am J Gastroenterol. 2021 May 4. pii: 00000434-900000000-98792.
    PubMed     Abstract available

  116. WANG R, Yang L, Hu C, Yan J, et al
    A Tip of the Iceberg on the Mechanism of SARS-CoV-2-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:1097-1098.

  117. BENMASSAOUD A, Tsochatzis E
    Response to Anand and Sharma.
    Am J Gastroenterol. 2021;116:1094-1095.

  118. BJORNSSON HK, Bjornsson ES
    Database Studies on Drug-Induced Liver Injury: The Importance of Causality Assessment.
    Am J Gastroenterol. 2021;116:1090-1091.

  119. CHALASANI NP, Maddur H, Russo MW, Wong RJ, et al
    ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury.
    Am J Gastroenterol. 2021;116:878-898.
    PubMed     Abstract available

  120. VILAR-GOMEZ E, Pirola CJ, Sookoian S, Wilson LA, et al
    Impact of the Association Between PNPLA3 Genetic Variation and Dietary Intake on the Risk of Significant Fibrosis in Patients With NAFLD.
    Am J Gastroenterol. 2021;116:994-1006.
    PubMed     Abstract available

  121. YATACO ML, Bowman AW, Keaveny AP
    Management of the Incidental Liver Lesion.
    Am J Gastroenterol. 2021;116:855-861.

  122. ESLAM M, Wong GL, Hashem AM, Chan HL, et al
    A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients.
    Am J Gastroenterol. 2021;116:984-993.
    PubMed     Abstract available

    April 2021
  123. GROVER I, Gunjan D, Singh N, Benjamin J, et al
    Effect of Vitamin D Supplementation on Vitamin D Level and Bone Mineral Density in Patients With Cirrhosis: A Randomized Clinical Trial.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98797.
    PubMed     Abstract available

  124. TRAN S, Jeong D, Henry L, Cheung RC, et al
    Initial Evaluation, Long-Term Monitoring, and Hepatocellular Carcinoma Surveillance of Chronic Hepatitis B in Routine Practice: A Nationwide US Study.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98796.
    PubMed     Abstract available

  125. THORNTON C, Somayaji R, Parkins M, Swain MG, et al
    Characteristics and Outcomes of Children With Cystic Fibrosis Hospitalized With Cirrhosis in the United States.
    Am J Gastroenterol. 2021 Apr 29. pii: 00000434-900000000-98795.
    PubMed     Abstract available

  126. MA C, Qian AS, Nguyen NH, Stukalin I, et al
    Trends in the Economic Burden of Chronic Liver Diseases and Cirrhosis in the United States: 1996-2016.
    Am J Gastroenterol. 2021 Apr 28. doi: 10.14309/ajg.0000000000001292.
    PubMed     Abstract available

  127. KAWAGUCHI Y, Hasegawa K, Hagiwara Y, De Bellis M, et al
    Effect of Diameter and Number of Hepatocellular Carcinomas on Survival After Resection, Transarterial Chemoembolization, and Ablation.
    Am J Gastroenterol. 2021 Apr 21. pii: 00000434-900000000-98811.
    PubMed     Abstract available

  128. SERPER M, Reddy KR, Bewtra M, Ahmad N, et al
    COVID-19 Vaccine Perceptions Among Patients With Chronic Disease in a Large Gastroenterology and Hepatology Practice.
    Am J Gastroenterol. 2021 Apr 19. pii: 00000434-900000000-98813.
    PubMed     Abstract available

  129. SHARMA S, Saraya A
    Avoiding Beta Blockers in Patients of Hepatitis C Virus-Related Compensated Cirrhosis With Clinically Significant Portal Hypertension After Cure With Antivirals: Are We There Yet?
    Am J Gastroenterol. 2021 Apr 9. pii: 00000434-900000000-98829.

  130. KHALILI M, Kleiner DE, King WC, Sterling RK, et al
    Hepatic Steatosis and Steatohepatitis in a Large North American Cohort of Adults With Chronic Hepatitis B.
    Am J Gastroenterol. 2021 Apr 8. pii: 00000434-900000000-98823.
    PubMed     Abstract available

  131. SONI D, Roy A, De A, Verma N, et al
    MASQ-HE: Unmasking the Predictors of Overt Hepatic Encephalopathy?
    Am J Gastroenterol. 2021;116:836-837.

  132. MORTON A
    Measuring Serum Sodium in Cirrhosis: Regarding "Hyponatremia in Cirrhosis: An Update".
    Am J Gastroenterol. 2021;116:835.

  133. PONS M, Augustin S, Scheiner B, Guillaume M, et al
    Noninvasive Diagnosis of Portal Hypertension in Patients With Compensated Advanced Chronic Liver Disease.
    Am J Gastroenterol. 2021;116:723-732.
    PubMed     Abstract available

  134. LAI JC, Dodge JL, Kappus MR, Wong R, et al
    A Multicenter Pilot Randomized Clinical Trial of a Home-Based Exercise Program for Patients With Cirrhosis: The Strength Training Intervention (STRIVE).
    Am J Gastroenterol. 2021;116:717-722.
    PubMed     Abstract available

  135. KOTANI K, Uchida-Kobayashi S, Yoshida K, Kawamura E, et al
    Lenvatinib-Induced Tumor-Related Hemorrhage in Patients With Unresectable Hepatocellular Carcinoma.
    Am J Gastroenterol. 2021;116:631.

  136. TAPPER EB
    Finding Common Ground With Our MASQs Off.
    Am J Gastroenterol. 2021;116:837.

  137. ALUKAL JJ, Thuluvath PJ
    Reply to Morton.
    Am J Gastroenterol. 2021;116:835-836.

  138. YAMADA G, Hagiwara Y, Kimura T, Takeuchi Y, et al
    Impact of Body Weight Gain on the Incidence of Nonalcoholic Fatty Liver Disease in Nonobese Japanese Individuals.
    Am J Gastroenterol. 2021;116:733-740.
    PubMed     Abstract available

  139. KOK B, McNeely M, Watt M, Tandon P, et al
    Exercise Only Works If You Do It! The Holy Grail of Adherence.
    Am J Gastroenterol. 2021;116:673-674.
    PubMed     Abstract available

    March 2021
  140. ROGAL S, Youk A, Agbalajobi O, Zhang H, et al
    Medication Treatment of Active Opioid Use Disorder in Veterans With Cirrhosis.
    Am J Gastroenterol. 2021 Mar 30. pii: 00000434-900000000-98834.
    PubMed     Abstract available

  141. GIL-GOMEZ A, Ampuero J, Rojas A, Gallego-Duran R, et al
    Development and Validation of a Clinical-Genetic Risk Score to Predict Hepatic Encephalopathy in Patients With Liver Cirrhosis.
    Am J Gastroenterol. 2021 Mar 2. pii: 00000434-900000000-98817.
    PubMed     Abstract available

    February 2021
  142. TAN HK, Teng MLP, Soh AYS, Cheo SHY, et al
    Poor Outcomes of Cirrhosis due to Nonalcoholic Steatohepatitis Compared With Hepatitis B After Decompensation With Ascites.
    Am J Gastroenterol. 2021 Feb 1. doi: 10.14309/ajg.0000000000001176.
    PubMed     Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.